Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center Phase I/II Study of NY-ESO-1 T Cell Receptor Gene Transferred T Lymphocytes in Patients with Synovial Sarcoma

NCT03250325 is registered in ClinicalTrials.gov with Takara Bio Inc. as lead sponsor.

NCT NCT03250325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03250325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center Phase I/II Study of NY-ESO-1 T Cell Receptor Gene Transferred T Lymphocytes in Patients with Synovial Sarcoma
Lead sponsor
Takara Bio Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
September 20, 2017
Completion date
March 9, 2022
Enrollment
8 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

synovial sarcoma